drugset / Trial / NCT07203144

Selenium Supplementation for Improving Depression in Children and Adolescents: Efficacy and Mechanistic Study

NCT07203144 ↗

Phase 2 Not yet recruiting 172 enrolled First Affiliated Hospital of Chongqing Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the role and mechanisms of selenium in depression among children and adolescents, aiming to provide new insights for understanding the pathogenesis and treatment of depression in this population.

Timeline

Start
2025-12-31
Primary completion
2027-04-01
Completion
2027-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject selenium yeast Unknown 60 ug —
Subject selenium yeast Unknown 200 ug —